MX336204B - Una composicion y uso de la misma en el tratamiento de ragades anales. - Google Patents

Una composicion y uso de la misma en el tratamiento de ragades anales.

Info

Publication number
MX336204B
MX336204B MX2014009244A MX2014009244A MX336204B MX 336204 B MX336204 B MX 336204B MX 2014009244 A MX2014009244 A MX 2014009244A MX 2014009244 A MX2014009244 A MX 2014009244A MX 336204 B MX336204 B MX 336204B
Authority
MX
Mexico
Prior art keywords
composition
treatment
anal rhagades
rhagades
anal
Prior art date
Application number
MX2014009244A
Other languages
English (en)
Other versions
MX2014009244A (es
Inventor
Filippo Bastia
Maurizio Saccomanno
Original Assignee
Thd Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46001672&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX336204(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Thd Spa filed Critical Thd Spa
Publication of MX2014009244A publication Critical patent/MX2014009244A/es
Publication of MX336204B publication Critical patent/MX336204B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Abstract

La invención presente se refiere a una composición que comprende por lo menos un extracto de proteína de hibisco y/o por lo menos un beta glucano o una sal del mismo; además, la invención presente se relaciona al uso de dicha composición para el tratamiento de rágades anales.
MX2014009244A 2012-01-30 2012-01-30 Una composicion y uso de la misma en el tratamiento de ragades anales. MX336204B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT2012/000027 WO2013114410A1 (en) 2012-01-30 2012-01-30 A composition and use thereof in the treatment of anal rhagades

Publications (2)

Publication Number Publication Date
MX2014009244A MX2014009244A (es) 2015-03-19
MX336204B true MX336204B (es) 2016-01-11

Family

ID=46001672

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014009244A MX336204B (es) 2012-01-30 2012-01-30 Una composicion y uso de la misma en el tratamiento de ragades anales.

Country Status (24)

Country Link
US (1) US9345747B2 (es)
EP (1) EP2646039B1 (es)
JP (1) JP5903505B2 (es)
KR (1) KR101599447B1 (es)
CN (2) CN104114177A (es)
AU (1) AU2012368815B2 (es)
BR (1) BR112014018850A8 (es)
CA (1) CA2863369C (es)
DK (1) DK2646039T3 (es)
ES (1) ES2485490T3 (es)
HK (1) HK1186378A1 (es)
HR (1) HRP20140594T1 (es)
IL (1) IL233875A (es)
IN (1) IN2014MN01733A (es)
MX (1) MX336204B (es)
PL (1) PL2646039T3 (es)
RS (1) RS53457B (es)
RU (1) RU2580622C2 (es)
SA (1) SA113340239B1 (es)
SG (1) SG11201404413UA (es)
SI (1) SI2646039T1 (es)
TW (1) TWI495476B (es)
WO (1) WO2013114410A1 (es)
ZA (1) ZA201405208B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6523291B2 (ja) 2013-12-24 2019-05-29 ザ プロクター アンド ギャンブル カンパニーＴｈｅ Ｐｒｏｃｔｅｒ ＆ Ｇａｍｂｌｅ Ｃｏｍｐａｎｙ スキンケア有効成分の高い浸透性を与える美容組成物及び方法
ITRM20150163A1 (it) * 2015-04-17 2016-10-17 Uniderm Farm S R L Composizioni farmaceutiche per il trattamento delle ragadi anali
US10117826B2 (en) 2016-03-31 2018-11-06 Peter Angia Pham Bodily lubricating and moisturizing compositions containing plant mucilage
US10835504B2 (en) 2018-04-18 2020-11-17 G&S Laboratories, Inc. Compositions to treat anal itch
WO2020022991A2 (en) * 2018-05-02 2020-01-30 Montero Gida Sanayi Ve Ticaret Anonim Sirketi Topical compositions for stretch marks on the skin
RU2771015C2 (ru) * 2020-09-25 2022-04-25 Общество с ограниченной ответственностью "ФАРМКОММ" Фармацевтическая композиция в виде мази для лечения геморроя

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622939A (en) * 1992-08-21 1997-04-22 Alpha-Beta Technology, Inc. Glucan preparation
ATE214266T1 (de) * 1997-04-16 2002-03-15 Cognis France Sa Verwendung einer aus hibiskus-esculentus-samen extrahierten proteinfraktion in der kosmetik
US6379719B1 (en) * 1998-04-08 2002-04-30 Laboratories Serobiologiques (Societe Anonyme) Use of at least one protein fraction extracted from Hibiscus esculentus seeds and cosmetic composition containing such a fraction
CN1233469A (zh) * 1998-04-28 1999-11-03 王京杭 组织修复促进剂
US6956120B2 (en) * 2000-11-09 2005-10-18 Yasushi Onaka β-1.3-1.6 glucan (Aureobasidium medium)
JP2002204687A (ja) * 2000-11-09 2002-07-23 Onaka Yasushi β−１．３−１．６グルカン（アウレオバシジウム培養液）の医療、保健、福祉、食品および各種産業分野での応用
JP2003104832A (ja) * 2001-09-28 2003-04-09 Chifure Keshohin:Kk 皮膚外用剤
JP4544500B2 (ja) 2002-07-19 2010-09-15 一丸ファルコス株式会社 ヒアルロン酸合成促進剤
CA2523021C (en) * 2003-05-02 2013-06-11 Ceapro Inc. Improved extraction and purification method for cereal beta-glucan
RU2277920C2 (ru) * 2004-02-24 2006-06-20 Государственное Учреждение "Пятигорский Государственный Научно-Исследовательский Институт Курортологии Министерства Здравоохранения Российской Федерации" Способ лечения детей, больных хроническим вирусным гепатитом, с применением сульфидных ванн и слабоуглекислой минеральной водой
ITMI20042111A1 (it) * 2004-11-04 2005-02-04 Biofarmitalia Spa Cerotto contenenti una sostanza scelta tra i catrami aventi caratteristiche riducenti in dermatologia
JP5048935B2 (ja) * 2005-08-24 2012-10-17 株式会社ヤクルト本社 保湿剤
DE202007004856U1 (de) * 2007-04-01 2007-06-06 Rühle, Wilfried, Dipl.-Ing. CHM Anti Aging Komplex
CN101095482B (zh) * 2007-07-05 2012-02-15 中国科学院长春应用化学研究所 制备膳食纤维食品用大麦麦麸或燕麦麦麸的制法
US20090202664A1 (en) * 2008-02-11 2009-08-13 Svetislav Mikalacki Herbal cream or oil for the treatment hemorroids and wounds
ITUD20100112A1 (it) * 2010-06-09 2011-12-10 Farma Derma S R L Preparazione per uso vaginale e rettale e relativo procedimento di produzione
CN102084963A (zh) * 2010-09-29 2011-06-08 吉林省农业机械研究院 一种制备燕麦麦麸膳食纤维食品的方法

Also Published As

Publication number Publication date
CN104114177A (zh) 2014-10-22
SA113340239B1 (ar) 2015-07-07
HRP20140594T1 (hr) 2014-10-24
BR112014018850A2 (es) 2017-06-20
IL233875A0 (en) 2014-09-30
RU2014129391A (ru) 2016-03-27
TWI495476B (zh) 2015-08-11
IL233875A (en) 2017-01-31
DK2646039T3 (da) 2014-08-11
HK1186378A1 (en) 2014-03-14
RS53457B (en) 2014-12-31
AU2012368815B2 (en) 2018-03-01
MX2014009244A (es) 2015-03-19
EP2646039A1 (en) 2013-10-09
JP2015504915A (ja) 2015-02-16
IN2014MN01733A (es) 2015-07-10
KR101599447B1 (ko) 2016-03-14
WO2013114410A1 (en) 2013-08-08
US20140303094A1 (en) 2014-10-09
CN109865000A (zh) 2019-06-11
KR20140127296A (ko) 2014-11-03
AU2012368815A1 (en) 2014-09-18
ES2485490T3 (es) 2014-08-13
ZA201405208B (en) 2015-10-28
CA2863369C (en) 2020-03-10
SI2646039T1 (sl) 2014-10-30
RU2580622C2 (ru) 2016-04-10
BR112014018850A8 (pt) 2017-07-11
JP5903505B2 (ja) 2016-04-13
CA2863369A1 (en) 2013-08-08
EP2646039B1 (en) 2014-05-14
US9345747B2 (en) 2016-05-24
PL2646039T3 (pl) 2014-10-31
TW201334787A (zh) 2013-09-01
SG11201404413UA (en) 2014-10-30

Similar Documents

Publication Publication Date Title
PH12019501393A1 (en) Afucosylated anti-fgfr2iiib antibodies
HK1215378A1 (zh) 藥物組合物、治療方法及其用途
PH12015502553A1 (en) Human binding molecules capable of binding to and neutralizing influenza b viruses and uses thereof
PH12014501738A1 (en) Piperidino-pyrimidine derivatives for the treatment of viral infections
PH12015500983A1 (en) Heterocyclic substituted 2-amino-quinazoline derivatives for the treatment of viral infections
IN2015DN03327A (es)
PH12014502406A1 (en) Anti-il-23p19 antibodies
MX2018000590A (es) Moleculas de anticuerpo que se unen a agrupacion de diferenciacion 79 (cd79).
TR201910866T4 (tr) Kanser tedavisi için birleşik preparasyonlar.
WO2014197835A3 (en) Methods and compositions for the treatment of cancer
IL241823B (en) Preparations containing novyi .c and their uses for the treatment of cancerous tumors
MX2014009244A (es) Una composicion y uso de la misma en el tratamiento de ragades anales.
PL3041831T3 (pl) Postacie soli alfa-TEA: kompozycje i zastosowania do leczenia choroby
MX2015010023A (es) Anticuerpos anti-cd83 y su uso.
UA117567C2 (uk) Композиція, яка стимулює лактацію, на основі фосфатидилсерину
MX2015008947A (es) Nuevas composiciones antifungicas.
TN2014000207A1 (en) Anti il-36r antibodies
IN2013CH00453A (es)
PH12014000104A1 (en) Therapeutic methods and compositions for treating diabetes